Hualan Biological Vaccine Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 34.22 million compared to CNY 144.76 million a year ago. Revenue was CNY 34.22 million compared to CNY 144.76 million a year ago.

Net income was CNY 38.59 million compared to CNY 93.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.0643 compared to CNY 0.1566 a year ago. Diluted earnings per share from continuing operations was CNY 0.0642 compared to CNY 0.1563 a year ago.